Assistant Professor, Internal Medicine, Ohio State University College of Medicine
Infectious Disease
Dr. Bradford S. McGwire, MD
|
|
Give Review
Bradford McGwire works in the field of Infectious Disease. He attended University of Illinois College of Medicine at Chicago. University of Illinois College of Medicine at Chicago is ranked 49/85 in Research/PrimaryCare. Bradford S. McGwire, MD is a published doctor and has 29 publications published. The lastest was: 'Kinetics of entry of virulent and avirulent strains of Leishmania donovani into macrophages: a possible role of virulence molecules (gp63 and LPG).' Dr. Bradford S. McGwire accepts Medicare payments and is registered with Medicare.gov.
Publications
- STAT-1 plays a critical role in control of Trypanosoma cruzi infection.
- Design of protease-resistant pexiganan enhances antileishmanial activity.
- Leishmaniasis: clinical syndromes and treatment.
- Mechanisms of cellular invasion by intracellular parasites.
- Voriconazole suppresses the growth of Leishmania species in vitro.
- Secreted trypanosome cyclophilin inactivates lytic insect defense peptides and induces parasite calcineurin-activation and infectivity.
- Iliopsoas coccidioidomycotic abscess with associated intra-abdominal extension in an immunocompetent patient.
- Molecular determinants of ciliary membrane localization of trypanosoma cruzi flagellar calcium-binding protein.
- Interactions of antimicrobial peptides with Leishmania and trypanosomes and their functional role in host parasitism.
- Antimicrobial peptide-induced apoptotic death of leishmania results from calcium-de pend ent, caspase-independent mitochondrial toxicity.
- Trypanosoma cruzi GP63 proteins undergo stage-specific differential posttranslational modification and are important for host cell infection.
- Fibronectin binding and proteolytic degradation by Leishmania and effects on macrophage activation.
- Infliximab and reactivation of cerebral toxoplasmosis.
- Killing of African trypanosomes by antimicrobial peptides.
- Migration through the extracellular matrix by the parasitic protozoan Leishmania is enhanced by surface metalloprotease gp63.
- Molecular determinants and regulation of Leishmania virulence.
- Extracellular release of the glycosylphosphatidylinositol (GPI)-linked Leishmania surface metalloprotease, gp63, is independent of GPI phospholipolysis: implications f...
- Interaction of Leishmania gp63 with cellular receptors for fibronectin.
- Roles of free GPIs in amastigotes of Leishmania.
- Kinetics of entry of virulent and avirulent strains of Leishmania donovani into macrophages: a possible role of virulence molecules (gp63 and LPG).
- Posttranslational regulation of a Leishmania HEXXH metalloprotease (gp63). The effects of site-specific mutagenesis of catalytic, zinc binding, N-glycosylation, and gl...
- A glycosylphosphatidylinositol (GPI)-negative phenotype produced in Leishmania major by GPI phospholipase C from Trypanosoma brucei: topography of two GPI pathways.
- GPI phospholipase C from Trypanosoma brucei causes a GPI-negative phenotype in Leishmania major: I. Implications for GPI-negative mammalian cells; II. Compartmentaliza...
- Genetic rescue of surface metalloproteinase (gp63)-deficiency in Leishmania amazonensis variants increases their infection of macrophages at the early phase.
- Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis.
- Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity.
- Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection.
- The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing.
Schools
University Of Illinois College Of Medicine Chicago
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- CareSource
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Humana
- Medicaid
- Medical Mutual of Ohio POS
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
University of Illinois College of Medicine at Chicago -
Rosalind Franklin University of Medicine and Science
Hospital
-
Ohio State University Wexner Medical Center -
Nationwide Children's Hospital
Drug Facts
| NPI NUMBER | 1497760979 | |
| NPPES Provider LastName | MCGWIRE | |
| NPPES Provider FirstName | BRADFORD | |
| NPPES Provider ZIPCode | 432101257 | |
| NPPES Provider State | OH | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 88.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497760979 |
| Last Name Of The Provider | MCGWIRE |
| First Name Of The Provider | BRADFORD |
| View All |
Similar Doctors
|
Dr. Susan L. Koletar, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Larry S. Schlesinger, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Amber M. Vasquez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ruth R. Mullowney-Agra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cora F. McNally, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Ian M. Baird, MB CHB
This Doctor is OpenDoctor Recommended.
|